Neuroglia is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system.
Authors are required to pay an article processing charge to publish in Neuroglia; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
function and pathology of glia, glial functions in development, disease and injuries, potential therapies for humans, glial cells, nervous system
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2021
ISSN
- electronic
- 2571-6980
Frequently asked questions
Is Neuroglia peer-reviewed?
Yes — Neuroglia operates a Anonymous peer review review process.
Does Neuroglia charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Neuroglia publish?
Neuroglia publishes research in Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system.
What languages does Neuroglia accept?
Neuroglia accepts manuscripts in English.
What is the ISSN of Neuroglia?
ISSN:
2571-6980 (electronic).How do I submit a manuscript to Neuroglia?
Submit through the journal's official portal: visit submission page →